title: Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD).
authors.forename: José
authors.initials: J
authors.lastname: Verdú
authors.forename: Pascual
authors.initials: P
authors.lastname: Marco
authors.forename: Susana
authors.initials: S
authors.lastname: Benlloch
authors.forename: José
authors.initials: J
authors.lastname: Sanchez
authors.forename: Javier
authors.initials: J
authors.lastname: Lucas
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D025901:Carboxypeptidase B2 / Q000097:blood* / Q000235:genetics*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D011110:Polymorphism, Genetic; D015203:Reproducibility of Results; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood* / Q000209:etiology; D020246:Venous Thrombosis / Q000097:blood* / Q000209:etiology
chemical_list: D015415:Biomarkers; D025901:Carboxypeptidase B2